Systematic review evidence indicates that patients with BP have an increased risk of neurologic disorders (risk ratio [RR]: 4.93, 95% CI: 3.62–6.70, I2 = 50.6%).2 BPAG1 and BPAG2 are expressed in both the skin and brain. The gene discussed is COL17A1; the disease is nervous system disorder.